Mehdi Touat

24PUBLICATIONS
185CO-AUTHORS
Molecular targetsGene and molecular therapyPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

|Apr 01, 2026
Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study.

Capucine Baldini, Philippe A Cassier, Jean-Pierre Delord

|Mar 09, 2026
Preserved IDH mutation and methylation class in vorasidenib nonresponders: A report of 2 cases.

Mehdi Touat, Jacqueline Lehmann-Che, Salah Eddine O Kacimi

|Feb 02, 2026
18F-DOPA-PET and Advanced MRI Improve Treatment Response Assessment in IDH1/2-Mutant Gliomas Treated with IDH Inhibitors.

Diego Prost, Lucia Nichelli, Laura Rozenblum

|Oct 09, 2025
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.

April A Apfelbaum, Eric Morin, Dominik Sturm

|Aug 19, 2025
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Patrick Y Wen, Michael Weller, Eudocia Q Lee

Pageof 4

Frequent Collaborators

7 joint publications

Patrick Y Wen

6 joint publications

David A Reardon

6 joint publications

Keith L Ligon

5 joint publications

Ahmed Idbaih